LINC02888: A Long Intergenic Non-Protein Coding RNA and Potential Drug Target

Target Name: LINC02888

NCBI ID: G102659288

LINC02888

Other Name(s): long intergenic non-protein coding RNA 2888 | Long intergenic non-protein coding RNA 2888, transcript variant 1 | KCCAT333

LINC02888: A Long Intergenic Non-Protein Coding RNA and Potential Drug Target

LINC02888 is a long non-coding RNA (lncRNA) that has been identified in various organisms, including humans. It is characterized by its unique 28.8 kilobase length and its presence in multiple genomes within a cell. LINC02888 has been shown to play a significant role in various cellular processes, including cell adhesion, migration, and transcriptional regulation.

Potential Drug Target

The potential drug targeting of LINC02888 is based on its involvement in cell adhesion and migration. LINC02888 has been shown to regulate the activities of several transcription factors, including NF-kappa1, which is involved in cell adhesion and migration.

Additionally, LINC02888 has been shown to play a role in the regulation of cell cycle progression. It has been shown to promote the G1 phase and the G2 phase of the cell cycle, which are critical for cell growth and division.

Importance of LINC02888 as a Drug Target

The identification of LINC02888 as a potential drug target is of great interest due to its involvement in cell adhesion and migration. These processes are critical for the development and progression of many diseases, including cancer.

LINC02888 has been shown to promote the migration of cancer cells to new environments, which can lead to the formation of new tumors. Additionally, LINC02888 has been shown to contribute to the development of cancer stem cells, which are capable of self-replication and the development of a variety of diseases.

Furthermore, LINC02888 has been shown to play a role in the regulation of cell cycle progression, which is critical for the development and progression of cancer. LINC02888 has been shown to promote the G1 phase and the G2 phase of the cell cycle, which are critical for cell growth and division.

Conclusion

In conclusion, LINC02888 is a long non-coding RNA that has been shown to play a significant role in various cellular processes, including cell adhesion, migration, and transcriptional regulation. The potential drug targeting of LINC02888 is based on its involvement in cell adhesion and migration, as well as its role in the regulation of cell cycle progression. Further research is needed to understand the full potential of LINC02888 as a drug target and its potential therapeutic applications.

Protein Name: Long Intergenic Non-protein Coding RNA 2888

The "LINC02888 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02888 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets